Fig. 2.
Fig. 2. T-cell stimulatory capacity of CBDC. (A) Graded doses of lin−- (CD3, CD11b, CD14, CD16, CD19, CD34, CD56, and glycophorin A negative) enriched CB cells were cocultured with 105 allogeneic CB T cells and after 5 days, BrdU uptake was determined (▪). Results are presented as mean ± SD of triplicates. Background BrdU uptake of lin−-enriched cells (□) and T cells (○) alone are shown. Statistical significance (**P < .01 and *P < .05) is indicated. (B) For the minimal number of lin− enriched stimulator cells (total, 2,557 ± 2,077; n = 11), which stimulated a significant response, the cell numbers of the lin−/HLA-DR+ (266 ± 107; n = 10), lin−/HLA-DR− (1,362 ± 1,476; n = 10), lin+/HLA-DR+ (192 ± 210; n = 9), and lin+/HLA-DR−(991 ± 1,168; n = 9) subpopulations, composing the lin−-enriched cells, are shown. The numbers of CD14+ monocytes (1,627 ± 642; n = 5) required for significant stimulation are indicated for comparison.

T-cell stimulatory capacity of CBDC. (A) Graded doses of lin- (CD3, CD11b, CD14, CD16, CD19, CD34, CD56, and glycophorin A negative) enriched CB cells were cocultured with 105 allogeneic CB T cells and after 5 days, BrdU uptake was determined (▪). Results are presented as mean ± SD of triplicates. Background BrdU uptake of lin-enriched cells (□) and T cells (○) alone are shown. Statistical significance (**P < .01 and *P < .05) is indicated. (B) For the minimal number of lin enriched stimulator cells (total, 2,557 ± 2,077; n = 11), which stimulated a significant response, the cell numbers of the lin/HLA-DR+ (266 ± 107; n = 10), lin/HLA-DR (1,362 ± 1,476; n = 10), lin+/HLA-DR+ (192 ± 210; n = 9), and lin+/HLA-DR(991 ± 1,168; n = 9) subpopulations, composing the lin-enriched cells, are shown. The numbers of CD14+ monocytes (1,627 ± 642; n = 5) required for significant stimulation are indicated for comparison.

Close Modal

or Create an Account

Close Modal
Close Modal